Jade Biosciences Ownership | Who Owns Jade Biosciences?
Jade Biosciences Ownership Summary
Jade Biosciences is owned by 52.56% institutional investors, 0.04% insiders, and 47.40% retail investors. Fmr is the largest institutional shareholder, holding 17.20% of JBIO shares.
JBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Jade Biosciences | 52.56% | 0.04% | 47.40% |
| Sector | Healthcare Stocks | 232.52% | 10.72% | -143.24% |
| Industry | Biotech Stocks | 384.56% | 10.59% | -295.14% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 4.89M | 17.20% | $42.19M |
| Fairmount funds management | 3.22M | 11.33% | $27.79M |
| Vr adviser | 3.22M | 11.33% | $27.79M |
| Blackrock funding, inc. /de | 2.87M | 7.25% | $44.29M |
| Vanguard group | 2.10M | 5.29% | $32.34M |
| Rtw investments, lp | 1.45M | 5.10% | $12.51M |
| Driehaus capital management | 1.26M | 4.42% | $10.84M |
| Avidity partners management lp | 1.13M | 3.96% | $9.73M |
| Versant venture management | 1.53M | 3.85% | $23.54M |
| Ra capital management | 1.06M | 3.74% | $9.17M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 1.53M | 15.59% | $23.54M |
| Fairmount funds management | 3.22M | 2.50% | $27.79M |
| Great point partners | 632.60K | 2.25% | $5.46M |
| Avidity partners management lp | 1.13M | 2.21% | $9.73M |
| Vr adviser | 3.22M | 1.56% | $27.79M |
| Samsara biocapital | 531.16K | 0.60% | $4.58M |
| Logos global management lp | 625.00K | 0.48% | $5.39M |
| Soleus capital management | 796.74K | 0.45% | $12.29M |
| Rtw investments, lp | 1.45M | 0.15% | $12.51M |
| Ra capital management | 1.06M | 0.11% | $9.17M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Abrdn | 867.28K | 0.02% | 867.28K |
| Blackrock funding, inc. /de | 2.87M | 0.00% | 720.11K |
| Vanguard group | 2.10M | 0.00% | 369.02K |
| State street | 499.29K | 0.00% | 180.52K |
| Geode capital management | 841.81K | 0.00% | 175.89K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -2.28M |
| Frazier life sciences management | - | - | -1.41M |
| Woodline partners lp | - | - | -106.27K |
| Goldman sachs group | 65.34K | 0.00% | -97.37K |
| Tcg crossover management | - | - | -64.02K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Abrdn | 867.28K | 0.02% | 867.28K | $13.38M |
| Wellington management group llp | 107.55K | 0.00% | 107.55K | $928.18K |
| Renaissance | 69.60K | 0.00% | 69.60K | $1.07M |
| Connor, clark & lunn investment management | 67.23K | 0.00% | 67.23K | $1.04M |
| Marshall wace, llp | 38.08K | 0.00% | 38.08K | $328.63K |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -5.00 |
| Glenmede investment management, lp | -53.00 |
| Tcg crossover management | -64.02K |
| Woodline partners lp | -106.27K |
| Frazier life sciences management | -1.41M |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | -1.32% | 20,804,363 | -34.20% | 52 | 0.82% | 55 | 77.42% | 10 | -54.55% |
| Sep 30, 2025 | 29 | -59.15% | 6,448,004 | -79.55% | 22 | 0.18% | 9 | -87.14% | 14 | - |
| Jun 30, 2025 | 32 | - | 6,707,208 | - | 134,144 | - | 32 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Frohlich Tom | Chief Executive Officer | Buy | $44.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
JBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools